Satsuma Pharmaceuticals Eulerpool Uudised

Satsuma Pharmaceuticals Eulerpool News

Satsuma Pharmaceuticals aktsia uudised

Satsuma Pharmaceuticals jälgivad paljud ajakirjanikud ja investorid üle kogu maailma. Kõige värskemad Satsuma Pharmaceuticals uudised paneme siia kokku.

• 17. juuli ·

  SeekingAlpha
  Leaven Partners Second Quarter 2023 Letter To Partners
• 9. juuni ·

  Benzinga
  Satsuma Pharmaceuticals And 2 Other Penny Stocks Insiders Are Aggressively Buying
• 18. mai ·

  Yahoo
  Satsuma Pharmaceuticals Announces FDA Acceptance of 505(b)(2) NDA for STS101, a Novel and Investigational Dihydroergotamine (DHE) Nasal Powder Product for the Acute Treatment of Migraine
• 18. mai ·

  Seeking Alpha
  Satsuma migraine therapy accepted for FDA review
• 18. mai ·

  Thefly.com
  Satsuma: FDA accepts NDA for STS101 for acute migraine treatment
• 15. mai ·

  TipRanks
  JonesTrading Sticks to Its Hold Rating for Satsuma Pharmaceuticals (STSA)
• 21. aprill ·

  Yahoo
  Satsuma Pharmaceuticals Announces Three Abstracts Accepted at The 75th American Academy of Neurology Annual Meeting
• 21. aprill ·

  Thefly.com
  Satsuma Pharmaceuticals announces three abstracts accepted at AAN meeting
• 19. aprill ·

  Thefly.com
  Biotech Alert: Searches spiking for these stocks today
• 19. aprill ·

  Fintel
  HC Wainwright & Co. Downgrades Satsuma Pharmaceuticals (STSA)